AET Stock UPDATES Aetna Inc (AET) 82.63 09/17/2014 13:20:18

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Aetna Inc (AET) 82.63 $AET

Midday Glance: Managed Care companies
AP - 1 hr 2 mins ago
NEW YORK (AP) — Shares of some top managed care companies are mixed at 1 p.m.:

Early Glance: Managed Care companies
AP - Wed Sep 17, 9:29AM CDT
NEW YORK (AP) — Shares of some top managed care companies are mixed at 10 a.m.:

Final Glance: Managed Care companies
AP - Tue Sep 16, 6:46PM CDT
NEW YORK (AP) — Shares of some top managed care companies were up at the close of trading:

Aetna Poised for Organic & Inorganic Growth, Risks Remain - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 16, 3:20PM CDT
Aetna (AET) is aggressively trying to grow through a mix of organic and organic ways in the industry faced with Health Reform challenges.

Expert Briefing on Health Care Sector Stocks - Edwards Lifesciences, Catamaran, Quest Diagnostics, Aetna, and WellPoint
PR Newswire - Mon Sep 15, 8:20AM CDT
On Friday, September 12, 2014, the NASDAQ Composite ended at 4,567.60, down 0.53%, the Dow Jones Industrial Average finished the day 0.36% lower at 16,987.51, and the S&P 500 closed at 1,985.54, down 0.60%. The losses were broad based as all the ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 736.69, down 0.69%, while the index has advanced 7.01% in the previous three months. Investor-Edge has initiated coverage on the following equities: Edwards Lifesciences Corporation (NYSE: EW), Catamaran Corporation (NASDAQ: CTRX), Quest Diagnostics Inc. (NYSE: DGX), Aetna Inc. (NYSE: AET), and WellPoint Inc. (NYSE: WLP). Free research on these five companies can be accessed at:

Market Activity, Upcoming Conference, Dividend, and New Agreement - Research Reports on Express Scripts, Boston Scientific, Zimmer, Medivation and Aetna
PR Newswire - Fri Sep 12, 8:15AM CDT
Today, Analysts Review released its research reports regarding Express Scripts Holding Company (NASDAQ: ESRX), Boston Scientific Corporation (NYSE: BSX), Zimmer Holdings, Inc. (NYSE: ZMH), Medivation Inc. (NASDAQ: MDVN) and Aetna Inc. (NYSE: AET). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6428-100free.

Coventry Health Care, CHI Health and UniNet Expand Collaboration to Deliver High-Quality, Lower-Cost Health Care to Omaha Residents
Business Wire - Thu Sep 11, 11:07AM CDT
Coventry Health Care, CHI Health and its provider-led clinically integrated network, UniNet, today announced an expansion to their collaboration that will offer Omaha residents under the age of 65 access to the same quality of care and affordability previously only offered to Medicare members.

Aetna Forms ACO in New York with Weill Cornell Physicians - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 10, 3:00PM CDT
Aetna (AET) continues to aggressively form ACOs to reduce medical costs and provide superior service to its members.

Coventry Health Care, CHI Health St. Elizabeth, CHI Health Nebraska Heart and UniNet Expand Collaboration to Deliver High-Quality, Lower-Cost Health Care Plan to Lincoln Residents
Business Wire - Wed Sep 10, 11:31AM CDT
Coventry Health Care, CHI Health St. Elizabeth, CHI Health Nebraska Heart and their provider-led clinically integrated network, UniNet, today announced an expansion to their collaboration that will offer Lincoln residents under the age of 65 access to the same quality of care and affordability previously only offered to Medicare members.

Coventry Health Care and Mercy Medical Center - Des Moines Expand Health Care Plan to Offer Des Moines Residents Greater Value
Business Wire - Wed Sep 10, 10:38AM CDT
Coventry Health Care, an Aetna company, and Mercy Medical Center - Des Moines (part of Catholic Health Initiatives), today announced an expansion of their existing collaboration that will offer Des Moines residents under the age of 65 access to the same quality of care and affordability previously only offered to Medicare members.

Aetna Rises 1.18% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Sep 09, 4:20PM CDT
Aetna (NYSE:AET) traded in a range yesterday that spanned from a low of $84.00 to a high of $84.95. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $84.15 on volume of 2.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 7

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 1

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 4

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 4

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 6

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading

Top 5 Most Recently Viewed Articles

Mouser Electronics Invites Engineers to Innovation Showcase

Updated Category News Views 56

Mouser Electronics planned to make waves at the Embedded World North America 2024, taking place from October 8 to 10. This inaugural event aimed to gather the crème de la crème of the embedded community under one roof, offering a fertile ground for innovation and knowledge exchange. Mouser's Showcase: What to Expect? With industry experts set to share insights through...

Continue Reading
Exploring the Growth Potential of the Exosome Research Market

Updated Category News Views 165

Exploring the Exosome Research Market Trends The global exosome research market is on an impressive trajectory, with projections estimating its value to reach around USD 961.41 million in the next decade. The growth is attributed to a staggering compound annual growth rate (CAGR) of approximately 17.47% during the period from 2025 to 2034. In 2024, the market was valued...

Continue Reading
Vivakor Engages in $3.5 Million Stock Offer for Growth

Updated Category News Views 145

Vivakor Engages in $3.5 Million Stock Offer for Growth Vivakor, Inc. (NASDAQ: VIVK), a company specializing in integrated energy infrastructure and environmental services, has recently announced a significant move in its financing strategy. This announcement involves a registered direct offering, through which the company anticipates raising approximately $3.5 million....

Continue Reading
BlackRock TCP Capital Corp. Gets Credit Ratings Boost

Updated Category News Views 115

In the gritty world of finance, ratings can make or break a company’s standing in the eyes of investors. Recently, BlackRock TCP Capital Corp. (NASDAQ: TCPC) snagged a much-coveted upgrade from Kroll Bond Rating Agency (KBRA), signaling robust operational health intertwined with strategic smarts. The new issuer and senior unsecured debt ratings of BBB- come laced with a...

Continue Reading
Investor Sentiment Shifts Amid Oil Price Concerns for ExxonMobil

Updated Category News Views 140

Falling Oil Prices Put Pressure on ExxonMobil ExxonMobil (NYSE: XOM) slipped 3.1% in a choppy trading session, giving back not only today’s gains but part of yesterday’s progress as well. The company’s share price often moves with crude, and this time that link is clear. What’s different now is that broader market forces are piling on, amplifying the slide and...

Continue Reading